Pubblicazioni

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

2020 - EXPERT OPINION ON BIOLOGICAL THERAPY
Pantano, F.; Russano, M.; Berruti, A.; Mansueto, G.; Migliorino, M. R.; Adamo, V.; Aprile, G.; Gelibter, A.; Ficorella, C.; Falcone, A.; Russo, A.; Aieta, M.; Maio, M.; Martelli, O.; Barni, S.; Napolitano, A.; Roca, E.; Quadrini, S.; Iacono, D.; Russo, A.; Calvetti, L.; Occhipinti, M.; Cortellini, A.; Vasile, E.; Passiglia, F.; Imperatori, M.; Calabro, L.; Di Giacomo, A. M.; Petrelli, F.; Pasquini, G.; Franchina, T.; Venditti, O.; Intagliata, S.; Galvano, A.; Fioroni, I.; Vincenzi, B.; Tonini, G.; Santini, D.

Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: The non-randomised ISID study

2020 - JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY
C., Verboon; B., Van Den Berg; D. R., Cornblath; E., Venema; K. C., Gorson; M. P., Lunn; H., Lingsma; P., Van Den Bergh; T., Harbo; K., Bateman; Y., Pereon; So. H., Sindrup; S., Kusunoki; J., Miller; Z., Islam; H. -P., Hartung; G., Chavada; B. C., Jacobs; R. A. C., Hughes; Addington, Van Doorn P. A. J. M.; (University of Virginia, Md; USA), Charlottesville; on October 7, S. Consortia. Protected by copyright.; Downloaded from 8 Verboon C, 2019 at Uppsala Universitet BIBSAM http://jnnp. bmj. com/ J Neurol Neurosurg Psychiatry: first published as 10. 1136/jnnp-2019-321496 on 5 October 2019.; J Neurol Neurosurg Psychiatry 2019, Et Al.; 1136/jnnp-2019-321496 Neuromuscular Ajroud-Driss, 0:1–9. doi:10.; (Northwestern University Feinberg, Md; USA), Chicago; Antonini, G.; (Mental Health and Sensory Organs (NESMOS), Md; University, Sapienza; Hospital, Sant’Andrea; Italy), Rome; Attarian, S.; Md, ; (CHU Timone, PhD; France), Marseille; Barroso, F. A.; (Instituto de Investigaciones Neurológicas Raúl Carrea, Md; Fleni, ; Aires, Buenos; Argentina), ; Benedetti, L.; Md, ; (Ospedale Sant’ Andrea La Spezia, PhD; Spezia, La; Italy), ; Bertorini, T. E.; (The University of Tennessee Health Science Center (UTHSC), Md; USA), Memphis; Brannagan, T. H.; (Columbia University, Md; York City, New; USA), ; Briani, C.; (University of Padova, Md; Italy), Padova; Bhavaraju-Sanka, R.; (University Hospital/University of Texas Health Science Center, Md; Antonio Texas, San; USA), ; Butterworth, S.; (Pinderfields Hospital, Md; UK), Wakefield; Casasnovas, C.; Md, ; Ciberer, PhD (Bellvitge University Hospital – IDIBELL Neurometabolic Diseases Group.; Spain), Barcelona; Cavaletti, G.; (University Milano-Bicocca, Md; Italy), Monza; Chen, S.; Md, ; (Rutgers, PhD; Wood Johnson University Hospital, Robert; Brunswick, New; USA), ; Claeys, K. G.; Md, ; University Hospitals Leuven, PhD (1.; Belgium, Leuven; KU Leuven, 2.; Belgium), Leuven; Cosgrove, J. S.; (Leeds General Infirmary, Md; UK), Leeds; Davidson, A.; (University of Glasgow, Md; UK), Glasgow; Dardiotis, E.; (University of Thessaly, Md; of Larissa, Hospital; Greece), Larissa; Dornonville de la Cour, C.; (National Hospital Copenhagen, Md; Denmark), Copenhagen; Faber, C. G.; Md, ; (Maastricht University Medical Centre, PhD; Maastricht, ; Netherlands), The; Feasby, T. E.; (University of Calgary, Md; Canada), Calgary; Fujioka, T.; (Toho University Medical Center, Md; Japan), Tokyo; Galassi, G.; (University Hospital of Modena, Md; Italy), Modena; Gilchrist, J. M.; (Soulthern Illinois University School of Medicine, Md; USA), Springfield; Goyal, N. A.; (University of California, Md; USA), Irvine; Granit, V.; (Montefiore Medical, Md; Center, ; York, New; USA), ; Gutiérrez-Gutiérrez, G.; (Hospital Universitario Infanta Sofia, Md; Sebastian, San; Spain), ; Hadden, R. D. M.; Md, ; (King’s College Hospital, PhD; UK), London; Holt, J. K. L.; PhD, ; (The Walton Centre, Frcp; UK), Liverpool; Htut, M.; George’s Hospital, MD (St.; UK), London; Jericó Pascual, I.; Md, ; (Complejo Hospitalario de Navarra, PhD; Spain), Pamplona; Karafiath, S.; (University of Utah School of Medicine, Md; Lake City, Salt; USA), ; Katzberg, H. D.; (University of Toronto, Md; Canada), Toronto; Kiers, L.; (University of Melbourne, Md; Melbourne Hospital, Royal; Australia), Parkville; Kieseier, B. C.; (Heinrich Heine University, Md; Germany), Düsseldorf; Kimpinski, K.; (University Hospital, Md; London-Ontario, Lhsc; Canada), ; Kuwabara, S.; Md, ; (Chiba University, PhD; Japan), Chiba; Kwan, J. Y.; (University of Maryland School of Medicine, Md; USA), Baltimore; Ladha, S. S.; (Barrow Neurology Clinics, Md; Arizona, Phoenix; USA), ; Lawson, V.; (Wexner Medical Center at The Ohio State University, Md; USA), Columbus; Lehmann, H.; Md, ; (University Hospital of Cologne, PhD; Köln, Universitätsklinikum; Germany), Cologne; Manji, H.; Md, ; (Ipswich Hospital, Frcp; UK), Ipswich; Marfia, G. A.; (Neurological Clinic

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity

2019 - JOURNAL FOR IMMUNOTHERAPY OF CANCER
Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.

A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD PATIENTS treated with or without inhaled steroids

2019 - EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Paone, G.; Lanata, L.; Saibene, F.; Toti, S.; Palermo, P.; Graziani, C.; Flore, M. C.; Ramaccia, M.; Puglisi, G.

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA
Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, Sébastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, Frédéric

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

2016 - EUROPEAN JOURNAL OF HAEMATOLOGY
Voso, Maria Teresa; Niscola, Pasquale; Piciocchi, Alfonso; Fianchi, Luana; Maurillo, Luca; Musto, Pellegrino; Pagano, Livio; Mansueto, Giovanna; Criscuolo, Marianna; ALOE SPIRITI, Maria Antonietta; Buccisano, Francesco; Venditti, Adriano; Tendas, Andrea; Piccioni, Anna Lina; Zini, Gina; Latagliata, Roberto; Filardi, Nunzio; Fragasso, Alberto; Fenu, Susanna; Breccia, Massimo

Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide

2015 - JOURNAL OF CLINICAL ONCOLOGY
Palassini, Elena; Ferrari, Stefano; Verderio, Paolo; Paoli, Antonino D.; Broto, Javier Martin; Quagliuolo, Vittorio; Comandone, Alessandro; Sangalli, Claudia; Palmerini, Emanuela; Lopez Pousa, Antonio; De Sanctis, Rita; Bottelli, Stefano; Libertini, Michela; Picci, Piero; Casali, Paolo G.; Gronchi, Alessandro

Adjuvant chemoradiotherapy in gastric cancer. a pooled analysis of the AIRO Gastrointestinal Group experience

2015 - TUMORI
Mattiucci, Gian Carlo; Valentini, Chiara; D'Agostino, Giuseppe Roberto; Augurio, Antonietta; Capirci, Carlo; De Paoli, Antonino; Genovesi, Domenico; Huscher, Alessandra; Iannone, Tiziana; Pani, Giuseppe; Rosetto, Maria Elena; Sciacero, Piera; Manfrida, Stefania; Corazzi, Francesca; Fusco, Vincenzo; Luppattelli, Marco; Mangiacotti, Maria Grazia; Melano, Antonella; Murino, Paola; Niespolo, Rita; Osti, Mattia Falchetto; Picardi, Vincenzo; Morganti, Alessio Giuseppe; Valentini, Vincenzo

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma